350 related articles for article (PubMed ID: 16533143)
1. Refractory epilepsy: mechanisms and solutions.
Kwan P; Brodie MJ
Expert Rev Neurother; 2006 Mar; 6(3):397-406. PubMed ID: 16533143
[TBL] [Abstract][Full Text] [Related]
2. Advances in epilepsy.
Kelso AR; Cock HR
Br Med Bull; 2004; 72():135-48. PubMed ID: 15845748
[TBL] [Abstract][Full Text] [Related]
3. Insights into the novel three 'D's of epilepsy treatment: drugs, delivery systems and devices.
Pathan SA; Jain GK; Akhter S; Vohora D; Ahmad FJ; Khar RK
Drug Discov Today; 2010 Sep; 15(17-18):717-32. PubMed ID: 20603226
[TBL] [Abstract][Full Text] [Related]
4. Potassium channels: brief overview and implications in epilepsy.
Benarroch EE
Neurology; 2009 Feb; 72(7):664-9. PubMed ID: 19221301
[No Abstract] [Full Text] [Related]
5. Central therapeutic effects of peripheral vagus nerve stimulation.
Gross M; Goyal M
Am J Electroneurodiagnostic Technol; 2007 Mar; 47(1):47-52. PubMed ID: 17503610
[TBL] [Abstract][Full Text] [Related]
6. Refractory epilepsy: clinical overview.
French JA
Epilepsia; 2007; 48 Suppl 1():3-7. PubMed ID: 17316406
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy of epilepsy: new armamentarium, new issues.
Vajda FJ
J Clin Neurosci; 2007 Sep; 14(9):813-23. PubMed ID: 17618119
[TBL] [Abstract][Full Text] [Related]
8. Monitoring gene changes during antiepileptic drug therapy to widen the safety window and reduce pharmacoresistance.
Glauser TA
Epilepsia; 2007; 48 Suppl 1():19-25. PubMed ID: 17316409
[TBL] [Abstract][Full Text] [Related]
9. [Drug-resistant epilepsy].
Nakken KO; Taubøll E
Tidsskr Nor Laegeforen; 2009 Oct; 129(19):1986-9. PubMed ID: 19823202
[TBL] [Abstract][Full Text] [Related]
10. Neuromodulation in epilepsy.
Al-Otaibi FA; Hamani C; Lozano AM
Neurosurgery; 2011 Oct; 69(4):957-79; discussion 979. PubMed ID: 21716154
[TBL] [Abstract][Full Text] [Related]
11. [Mechanisms of drug resistance in epilepsy].
Lasoń W
Przegl Lek; 2006; 63(11):1218-20. PubMed ID: 17348420
[TBL] [Abstract][Full Text] [Related]
12. Innovative clinical trial designs for future antiepileptic drugs.
Dichter MA
Epilepsia; 2007; 48 Suppl 1():26-30. PubMed ID: 17316410
[TBL] [Abstract][Full Text] [Related]
13. Drug transporters in the epileptic brain.
Löscher W
Epilepsia; 2007; 48 Suppl 1():8-13. PubMed ID: 17316407
[TBL] [Abstract][Full Text] [Related]
14. Refractory epilepsy: a clinically oriented review.
Beleza P
Eur Neurol; 2009; 62(2):65-71. PubMed ID: 19521080
[TBL] [Abstract][Full Text] [Related]
15. [Future perspectives in epilepsy treatment].
Wieser HG
Praxis (Bern 1994); 1996 Jan; 85(4):102-5. PubMed ID: 8578054
[TBL] [Abstract][Full Text] [Related]
16. Vagus nerve stimulation therapy for treatment of drug-resistant epilepsy and depression.
Shafique S; Dalsing MC
Perspect Vasc Surg Endovasc Ther; 2006 Dec; 18(4):323-7. PubMed ID: 17351201
[TBL] [Abstract][Full Text] [Related]
17. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy.
Luciano AL; Shorvon SD
Ann Neurol; 2007 Oct; 62(4):375-81. PubMed ID: 17253624
[TBL] [Abstract][Full Text] [Related]
18. Intranasal anticonvulsive treatment: a prospective management of intractable epilepsy?
Tan L; Yu JT; Guan HS
Med Hypotheses; 2008 Oct; 71(4):542-5. PubMed ID: 18614291
[TBL] [Abstract][Full Text] [Related]
19. Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches.
Potschka H
Pharmacogenomics; 2010 Oct; 11(10):1427-38. PubMed ID: 21047204
[TBL] [Abstract][Full Text] [Related]
20. TRPV1: a potential target for antiepileptogenesis.
Fu M; Xie Z; Zuo H
Med Hypotheses; 2009 Jul; 73(1):100-2. PubMed ID: 19328632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
